AKYA – akoya biosciences, inc. (US:NASDAQ)
Stock Stats
News
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $3.00 price target on the stock, down previously from $4.00.
Time To Worry? Analysts Just Downgraded Their Akoya Biosciences, Inc. (NASDAQ:AKYA) Outlook [Yahoo! Finance]
Akoya Biosciences Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $6.00 to $3.50. They now have a "buy" rating on the stock.
Akoya Biosciences, Inc. (NASDAQ: AKYA) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating. They now have a $5.00 price target on the stock, down previously from $7.00.
Form 4 Akoya Biosciences, Inc. For: Nov 19 Filed by: Kamocsay Jennifer
Form 4 Akoya Biosciences, Inc. For: Nov 19 Filed by: Ek John Frederick
Form 4 Akoya Biosciences, Inc. For: Nov 19 Filed by: Ramachandran Niro Ph.D
Form 4 Akoya Biosciences, Inc. For: Nov 19 Filed by: BAMFORD PASCAL
Form 4 Akoya Biosciences, Inc. For: Nov 19 Filed by: McKelligon Brian
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.